MiNK Therapeutics (INKT) Stock Chart & Stock Price History → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free INKT Stock Alerts $0.90 -0.03 (-3.30%) (As of 05:21 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media MiNK Therapeutics Stock Price Performance5 Day Performance-7.20%1 Month Performance-9.96%3 Month Performance-0.07%6 Month Performance-18.80%Year-To-Date Performance-15.01%1 Year Performance-46.19% Receive INKT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. INKT Stock Chart for Thursday, May, 9, 2024 INKT Chart by TradingView MiNK Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$0.93$0.93-0.01%$0.95$0.9218,971 shs$32.27 million05/07/2024$0.94$0.93-1.13%$0.97$0.9258,814 shs$32.27 million05/06/2024$0.98$0.94-4.01%$1.01$0.94118,587 shs$32.64 million05/03/2024$0.97$0.98+1.09%$0.99$0.9428,781 shs$34.01 million05/02/2024$0.95$0.97+1.77%$0.97$0.9240,059 shs$33.64 million05/01/2024$0.99$0.95-3.79%$0.99$0.9379,937 shs$33.05 million Get the Latest News and Ratings for INKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$0.95$0.99+4.20%$0.99$0.9333,909 shs$34.35 million04/29/2024$0.93$0.95+2.44%$0.98$0.9158,163 shs$32.97 million04/26/2024$0.87$0.93+6.46%$0.93$0.8832,348 shs$32.18 million04/25/2024$0.89$0.87-2.00%$0.92$0.8638,201 shs$30.23 million04/24/2024$0.87$0.89+2.07%$0.93$0.8637,583 shs$30.85 million04/23/2024$0.89$0.87-2.57%$0.93$0.8792,040 shs$30.22 million04/22/2024$0.88$0.89+2.02%$0.91$0.8639,998 shs$31.02 million04/19/2024$0.87$0.88+0.53%$0.90$0.8640,310 shs$30.41 million04/18/2024$0.92$0.87-4.76%$0.96$0.8742,419 shs$30.25 million04/17/2024$0.92$0.92-0.51%$0.93$0.8924,277 shs$31.76 million04/16/2024$0.91$0.92+1.27%$0.94$0.8941,947 shs$31.92 million04/15/2024$0.98$0.91-7.74%$1.02$0.8976,569 shs$31.53 million04/12/2024$1.02$0.98-3.46%$1.03$0.9762,500 shs$34.17 million04/11/2024$1.00$1.02+2.00%$1.05$0.9823,757 shs$35.39 million04/10/2024$1.01$1.00-0.99%$1.11$0.9867,752 shs$34.70 million04/09/2024$1.32$1.01-23.48%$1.37$0.98410,810 shs$35.05 million04/08/2024$1.56$1.32-15.38%$1.58$1.21458,124 shs$45.80 million04/05/2024$1.34$1.56+16.42%$1.90$1.341.52 million shs$54.13 million04/04/2024$0.96$1.34+38.89%$1.35$0.94765,001 shs$46.50 million04/03/2024$0.94$0.96+2.64%$0.98$0.9358,319 shs$33.48 million04/02/2024$0.95$0.94-0.88%$0.96$0.9135,535 shs$32.62 million04/01/2024$0.91$0.95+4.40%$0.95$0.9136,107 shs$32.91 million03/29/2024$0.91$0.91$0.93$0.9035,116 shs$31.52 million03/28/2024$0.91$0.91-0.19%$0.93$0.9035,063 shs$31.52 million03/27/2024$0.94$0.91-2.99%$0.93$0.9134,109 shs$31.58 million03/26/2024$0.92$0.94+1.96%$0.94$0.9035,831 shs$32.55 million03/25/2024$0.87$0.92+5.75%$0.92$0.8744,343 shs$31.92 million03/22/2024$0.89$0.87-2.25%$0.89$0.8732,131 shs$30.03 million03/21/2024$0.90$0.89-0.67%$0.91$0.8646,506 shs$30.72 million03/20/2024$0.86$0.90+4.19%$0.91$0.7866,272 shs$30.93 million03/19/2024$0.86$0.86$0.91$0.8518,941 shs$29.69 million03/18/2024$0.89$0.86-3.86%$0.91$0.8638,118 shs$29.69 million03/15/2024$0.89$0.89+0.51%$0.91$0.8138,273 shs$30.88 million03/14/2024$0.91$0.89-2.20%$0.92$0.82143,886 shs$30.72 millionThe 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. 03/13/2024$0.91$0.91-0.22%$0.95$0.9051,739 shs$31.41 million03/12/2024$0.95$0.91-3.96%$0.97$0.9125,945 shs$31.48 million03/11/2024$0.96$0.95-1.29%$0.99$0.9050,188 shs$32.78 million03/08/2024$0.93$0.96+3.33%$0.97$0.9222,834 shs$33.21 million03/07/2024$0.98$0.93-4.61%$0.98$0.9343,887 shs$32.14 million03/06/2024$0.98$0.98-0.41%$0.99$0.9288,863 shs$33.69 million03/05/2024$0.98$0.98+0.22%$1.01$0.9363,502 shs$33.83 million03/04/2024$0.95$0.98+2.93%$1.02$0.9497,289 shs$33.75 million03/01/2024$0.92$0.95+3.12%$0.98$0.9229,112 shs$32.79 million02/29/2024$0.95$0.92-3.26%$1.00$0.9152,947 shs$31.80 million02/28/2024$0.94$0.95+1.39%$0.98$0.9262,278 shs$32.87 million02/27/2024$0.92$0.94+1.94%$0.95$0.9334,058 shs$32.42 million02/26/2024$0.90$0.92+2.37%$0.93$0.909,451 shs$31.80 million02/23/2024$0.93$0.90-2.93%$0.94$0.8935,711 shs$31.07 million02/22/2024$0.92$0.93+0.78%$0.94$0.8840,412 shs$32.01 million02/21/2024$0.94$0.92-2.01%$0.95$0.9131,061 shs$31.76 million02/20/2024$0.92$0.94+2.17%$0.95$0.9119,327 shs$32.41 million02/19/2024$0.92$0.92$0.97$0.8850,300 shs$31.72 million02/16/2024$0.93$0.92-1.18%$0.97$0.8850,336 shs$31.72 million02/15/2024$1.00$0.93-6.96%$1.04$0.90105,199 shs$32.10 million02/14/2024$0.93$1.00+7.75%$1.00$0.9247,970 shs$34.51 million02/13/2024$0.94$0.93-1.37%$0.93$0.9022,097 shs$32.02 million02/12/2024$0.91$0.94+3.36%$0.97$0.9136,466 shs$32.47 million02/09/2024$0.86$0.91+5.36%$0.91$0.8529,511 shs$31.41 million02/08/2024$0.84$0.86+2.53%$0.90$0.80157,761 shs$29.82 million Related Companies: Surrozen Stock Chart Protara Therapeutics Stock Chart Achilles Therapeutics Stock Chart Pluri Stock Chart NKGen Biotech Stock Chart Cortexyme Stock Chart Estrella Immunopharma Stock Chart SAB Biotherapeutics Stock Chart Brainstorm Cell Therapeutics Stock Chart Quince Therapeutics Stock Chart Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INKT) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.